These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31864703)

  • 1. Structural basis for the recognition of RFX7 by ANKRA2 and RFXANK.
    Gao J; Xu C
    Biochem Biophys Res Commun; 2020 Feb; 523(1):263-266. PubMed ID: 31864703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence-specific recognition of a PxLPxI/L motif by an ankyrin repeat tumbler lock.
    Xu C; Jin J; Bian C; Lam R; Tian R; Weist R; You L; Nie J; Bochkarev A; Tempel W; Tan CS; Wasney GA; Vedadi M; Gish GD; Arrowsmith CH; Pawson T; Yang XJ; Min J
    Sci Signal; 2012 May; 5(226):ra39. PubMed ID: 22649097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ankyrin repeats of ANKRA2 recognize a PxLPxL motif on the 3M syndrome protein CCDC8.
    Nie J; Xu C; Jin J; Aka JA; Tempel W; Nguyen V; You L; Weist R; Min J; Pawson T; Yang XJ
    Structure; 2015 Apr; 23(4):700-12. PubMed ID: 25752541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 target ANKRA2 cooperates with RFX7 to regulate tumor suppressor genes.
    Schwab K; Riege K; Coronel L; Stanko C; Förste S; Hoffmann S; Fischer M
    Cell Death Discov; 2024 Aug; 10(1):376. PubMed ID: 39181888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class II histone deacetylases confer signal responsiveness to the ankyrin-repeat proteins ANKRA2 and RFXANK.
    McKinsey TA; Kuwahara K; Bezprozvannaya S; Olson EN
    Mol Biol Cell; 2006 Jan; 17(1):438-47. PubMed ID: 16236793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the ankyrin repeat proteins ANKRA and RFXANK as novel partners of class IIa histone deacetylases.
    Wang AH; Grégoire S; Zika E; Xiao L; Li CS; Li H; Wright KL; Ting JP; Yang XJ
    J Biol Chem; 2005 Aug; 280(32):29117-27. PubMed ID: 15964851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.
    Wiszniewski W; Fondaneche MC; Louise-Plence P; Prochnicka-Chalufour A; Selz F; Picard C; Le Deist F; Eliaou JF; Fischer A; Lisowska-Grospierre B
    Immunogenetics; 2003 Feb; 54(11):747-55. PubMed ID: 12618906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.
    Krawczyk M; Masternak K; Zufferey M; Barras E; Reith W
    Mol Cell Biol; 2005 Oct; 25(19):8607-18. PubMed ID: 16166641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structure of GABPalpha/beta: an ETS domain- ankyrin repeat heterodimer bound to DNA.
    Batchelor AH; Piper DE; de la Brousse FC; McKnight SL; Wolberger C
    Science; 1998 Feb; 279(5353):1037-41. PubMed ID: 9461436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA binding domain of RFX5: interactions with X-box DNA and RFXANK.
    Chakraborty M; Sengupta A; Bhattacharya D; Banerjee S; Chakrabarti A
    Biochim Biophys Acta; 2010 Oct; 1804(10):2016-24. PubMed ID: 20637319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of ankyrin repeats reveals how a single point mutation in RFXANK results in bare lymphocyte syndrome.
    Nekrep N; Geyer M; Jabrane-Ferrat N; Peterlin BM
    Mol Cell Biol; 2001 Aug; 21(16):5566-76. PubMed ID: 11463838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
    Masternak K; Barras E; Zufferey M; Conrad B; Corthals G; Aebersold R; Sanchez JC; Hochstrasser DF; Mach B; Reith W
    Nat Genet; 1998 Nov; 20(3):273-7. PubMed ID: 9806546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor RFX7 governs a tumor suppressor network in response to p53 and stress.
    Coronel L; Riege K; Schwab K; Förste S; Häckes D; Semerau L; Bernhart SH; Siebert R; Hoffmann S; Fischer M
    Nucleic Acids Res; 2021 Jul; 49(13):7437-7456. PubMed ID: 34197623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for spectrin recognition by ankyrin.
    Ipsaro JJ; Mondragón A
    Blood; 2010 May; 115(20):4093-101. PubMed ID: 20101027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RFX7 is required for the formation of cilia in the neural tube.
    Manojlovic Z; Earwood R; Kato A; Stefanovic B; Kato Y
    Mech Dev; 2014 May; 132():28-37. PubMed ID: 24530844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ankyrin(g) ETS domains to DNA.
    Ely KR; Kodandapani R
    Nat Struct Biol; 1998 Apr; 5(4):255-9. PubMed ID: 9546211
    [No Abstract]   [Full Text] [Related]  

  • 17. Structural basis of diverse membrane target recognitions by ankyrins.
    Wang C; Wei Z; Chen K; Ye F; Yu C; Bennett V; Zhang M
    Elife; 2014 Nov; 3():. PubMed ID: 25383926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding.
    Gajiwala KS; Chen H; Cornille F; Roques BP; Reith W; Mach B; Burley SK
    Nature; 2000 Feb; 403(6772):916-21. PubMed ID: 10706293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the human RFX transcription factor family by regulatory and target gene analysis.
    Sugiaman-Trapman D; Vitezic M; Jouhilahti EM; Mathelier A; Lauter G; Misra S; Daub CO; Kere J; Swoboda P
    BMC Genomics; 2018 Mar; 19(1):181. PubMed ID: 29510665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.